ArticleCancers2021

Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma.

Shinichi Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.